Literature DB >> 16344510

Adult botulism type F in the United States, 1981-2002.

A Gupta1, C J Sumner, M Castor, S Maslanka, J Sobel.   

Abstract

BACKGROUND: Clostridium botulinum neurotoxin types A, B, and E cause most cases of the paralytic disease botulism. Little is known about the epidemiology, clinical features, or microbiology of botulism type F.
METHODS: Cases of adult type F botulism were identified by review of data collected by CDC's National Botulism Surveillance System between 1981 and 2002. A case was either an individual whose serum or stool demonstrated type F toxin or whose stool culture yielded an organism producing toxin type F. A detailed review of cases' medical charts and laboratory data from CDC and local health departments was performed.
RESULTS: Between 1981 and 2002, 1,269 cases of botulism among adults and infants were reported to CDC; 13 (1%) were adult type F. The median age of type F cases was 54 years; 7 (54%) were female. None were part of outbreaks. A toxigenic Clostridium baratii was identified in 9 (69%) of 13 cases. Among 11 cases for which clinical data were available, all required mechanical ventilation for a median duration of 17 days (range, 10 to 84); 8 (73%) were intubated within 24 hours of symptom onset. All patients had nearly complete or complete quadriplegia at the nadir of neurologic dysfunction, which occurred on average on day 5. On average by day 8, improvement in neuromuscular function was noted. The median duration of acute hospitalization was 31 days (range, 20 to 60). No deaths were reported. In only one case was a possible foodborne etiology identified.
CONCLUSIONS: Toxigenic C baratii are the sole documented causes of type F botulism in the United States since 1981. These cases are characterized by a fulminant course with rapid progression to respiratory failure and paralysis, making early recognition and intervention critical to appropriate management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344510     DOI: 10.1212/01.wnl.0000187127.92446.4c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Lung abscess due to Clostridium baratii infection in a patient with invasive pulmonary aspergillosis.

Authors:  Chin-Chung Shu; Ming Yao; Chien-Ching Hung; Shih-Chi Ku; Chong-Jen Yu; Yih-Leong Chang
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

2.  Diversity of culturable psychrophilic and psychrotrophic anaerobic bacteria isolated from beef abattoirs and their environments.

Authors:  G Moschonas; D J Bolton; D A McDowell; J J Sheridan
Journal:  Appl Environ Microbiol       Date:  2011-04-15       Impact factor: 4.792

3.  Clinically and electrophysiologically diagnosed botulinum intoxication.

Authors:  Dilcan Kotan; Recep Aygul; Mustafa Ceylan; Yalcin Yilikoglu
Journal:  BMJ Case Rep       Date:  2013-01-03

4.  Clostridium botulinum strains producing BoNT/F4 or BoNT/F5.

Authors:  Brian H Raphael; Marite Bradshaw; Suzanne R Kalb; Lavin A Joseph; Carolina Lúquez; John R Barr; Eric A Johnson; Susan E Maslanka
Journal:  Appl Environ Microbiol       Date:  2014-03-14       Impact factor: 4.792

5.  Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").

Authors:  Sabine Pellett; William H Tepp; Guangyun Lin; Eric A Johnson
Journal:  Toxicon       Date:  2017-12-19       Impact factor: 3.033

6.  Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016.

Authors:  John C O'Horo; Eugene P Harper; Abdelghani El Rafei; Rashid Ali; Daniel C DeSimone; Amra Sakusic; Omar M Abu Saleh; Jasmine R Marcelin; Eugene M Tan; Agam K Rao; Jeremy Sobel; Pritish K Tosh
Journal:  Clin Infect Dis       Date:  2017-12-27       Impact factor: 9.079

7.  Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins.

Authors:  Suzanne R Kalb; Jakub Baudys; Christina Egan; Theresa J Smith; Leonard A Smith; James L Pirkle; John R Barr
Journal:  Appl Environ Microbiol       Date:  2010-12-17       Impact factor: 4.792

8.  Botulism mortality in the USA, 1975-2009.

Authors:  Kelly A Jackson; Barbara E Mahon; John Copeland; Ryan P Fagan
Journal:  Botulinum J       Date:  2016-08-04

9.  Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

Authors:  Theresa J Smith; Karen K Hill; Gary Xie; Brian T Foley; Charles H D Williamson; Jeffrey T Foster; Shannon L Johnson; Olga Chertkov; Hazuki Teshima; Henry S Gibbons; Lauren A Johnsky; Mark A Karavis; Leonard A Smith
Journal:  Infect Genet Evol       Date:  2014-12-06       Impact factor: 3.342

10.  Clinical recovery and circulating botulinum toxin type F in adult patient.

Authors:  Jeremy Sobel; Tracy Dill; Christina L Kirkpatrick; Laurel Riek; Patrick Luedtke; Todd A Damrow
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.